CTAP TFA,99.56%

产品编号:Bellancom-P1335A| 分子式:C53H70F3N13O12S2| 分子量:1218.32

本网站销售的所有产品仅用于工业应用或者科学研究等非医疗目的,不可用于人类或动物的临床诊断或者治疗,非药用,非食用,

货号 包装 价格 库存与货期 购买量 操作
Bellancom-P1335A
2200.00 杭州 北京(现货)
Bellancom-P1335A
5500.00 杭州 北京(现货)
Bellancom-P1335A
9300.00 杭州 北京(现货)

增值税发票√顺丰快递√订货电话:18601927057

CTAP TFA

产品介绍 CTAP TFA 是一种强效、高选择性的、可透过血脑屏障的阿片受体 (μ opioid receptor) 拮抗剂,IC50 为 3.5 nM。CTAP TFA 对 δ opioid 受体 (IC50=4500 nM) 和生长抑素受体 (somatostatin receptors) 具有超过 1200 倍的选择性。CTAP TFA 可用于L -多巴胺 (HY-N0304) 诱导的运动障碍 (LID) 和阿片类活性分子过量或成瘾的研究。
生物活性

CTAP TFA is a potent, highly selective, and BBB penetrant μ opioid receptor antagonist, with an IC50 of 3.5 nM. CTAP TFA displays over 1200-fold selectivity over δ opioid (IC50=4500 nM) and somatostatin receptors. CTAP TFA can be used for the study of L-DOPA-induced dyskinesia (LID) and opiate overdose or addiction.

体外研究
体内研究

CTAP TFA (0-1 mg/kg, IP, single) blocks morphine’s antinociceptive effect.
CTAP TFA (10 mg/kg; IP, single) has no effect on L-DOPA-induced limb, axial, orolingual, or locomotor abnormal involuntary movements.
CTAP TFA is stable in the blood and serum of rats (T1/2 > 500 min), showing that the structure of this peptide offers enzymatic resistance.
CTAP TFA is extensively protein-bound to albumin in the perfusion medium (68.2%) and to proteins in rat serum (84.2%).

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Sprague-Dawley rats
Dosage: 0, 0.1, 0.5, 1 mg/kg
Administration: IP, single
Result: Completely blocked morphine’s antinociceptive effect at 0.5 or 1 mg/kg.
体内研究

CTAP TFA (0-1 mg/kg, IP, single) blocks morphine’s antinociceptive effect.
CTAP TFA (10 mg/kg; IP, single) has no effect on L-DOPA-induced limb, axial, orolingual, or locomotor abnormal involuntary movements.
CTAP TFA is stable in the blood and serum of rats (T1/2 > 500 min), showing that the structure of this peptide offers enzymatic resistance.
CTAP TFA is extensively protein-bound to albumin in the perfusion medium (68.2%) and to proteins in rat serum (84.2%).

西域 has not independently confirmed the accuracy of these methods. They are for reference only.

Animal Model: Male Sprague-Dawley rats
Dosage: 0, 0.1, 0.5, 1 mg/kg
Administration: IP, single
Result: Completely blocked morphine’s antinociceptive effect at 0.5 or 1 mg/kg.
性状Solid
溶解性数据
In Vitro: 

H2O : 100 mg/mL (82.08 mM; Need ultrasonic)

配制储备液
浓度 溶剂体积 质量 1 mg 5 mg 10 mg
1 mM 0.8208 mL 4.1040 mL 8.2080 mL
5 mM 0.1642 mL 0.8208 mL 1.6416 mL
10 mM 0.0821 mL 0.4104 mL 0.8208 mL
*

请根据产品在不同溶剂中的溶解度选择合适的溶剂配制储备液;一旦配成溶液,请分装保存,避免反复冻融造成的产品失效
储备液的保存方式和期限:-80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)。-80°C 储存时,请在 6 个月内使用,-20°C 储存时,请在 1 个月内使用。

运输条件

Room temperature in continental US; may vary elsewhere.

储存方式

Sealed storage, away from moisture and light, under nitrogen

Powder -80°C 2 years
-20°C 1 year

*In solvent : -80°C, 6 months; -20°C, 1 month (sealed storage, away from moisture and light, under nitrogen)

参考文献

相关文档

化学品安全说明书(MSDS)

下载MSDS

质检证书(COA)

相关产品


服务热线

13911702513
18601927057

微信客服